XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2020   5,916,000      
Beginning balance at Sep. 30, 2020 $ 45,523 $ 5,916 $ 10,736 $ 42,339 $ (13,468)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 1,908     1,502 406
Performance and restricted share expense 293   293    
Share transactions under equity based plans (in shares)   73,000      
Share transactions under equity based plans (16) $ 73 (89)    
Ending balance (in shares) at Mar. 31, 2021   5,989,000      
Ending balance at Mar. 31, 2021 47,708 $ 5,989 10,940 43,841 (13,062)
Beginning balance (in shares) at Dec. 31, 2020   5,959,000      
Beginning balance at Dec. 31, 2020 49,141 $ 5,959 10,820 45,332 (12,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (1,583)     (1,491) (92)
Performance and restricted share expense 150   150    
Share transactions under equity based plans (in shares)   30,000      
Share transactions under equity based plans 0 $ 30 (30)    
Ending balance (in shares) at Mar. 31, 2021   5,989,000      
Ending balance at Mar. 31, 2021 47,708 $ 5,989 10,940 43,841 (13,062)
Beginning balance (in shares) at Sep. 30, 2021   5,987,000      
Beginning balance at Sep. 30, 2021 49,622 $ 5,987 11,118 41,596 (9,079)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (73)     (52) (21)
Performance and restricted share expense 306   306    
Share transactions under equity based plans (in shares)   53,000      
Share transactions under equity based plans (107) $ 53 (160)    
Ending balance (in shares) at Mar. 31, 2022   6,040,000      
Ending balance at Mar. 31, 2022 49,748 $ 6,040 11,264 41,544 (9,100)
Beginning balance (in shares) at Dec. 31, 2021   6,003,000      
Beginning balance at Dec. 31, 2021 45,981 $ 6,003 11,156 37,905 (9,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 3,622     3,639 (17)
Performance and restricted share expense 145   145    
Share transactions under equity based plans (in shares)   37,000      
Share transactions under equity based plans 0 $ 37 (37)    
Ending balance (in shares) at Mar. 31, 2022   6,040,000      
Ending balance at Mar. 31, 2022 $ 49,748 $ 6,040 $ 11,264 $ 41,544 $ (9,100)